EUVIMEDEUVIMED entdecken
Crossref

Microglial LRRK2 ‐mediated NFATc1 attenuates α‐synuclein immunotoxicity in association with CX3CR1 ‐induced migration and the lysosome‐initiated degradation

Linjuan Feng, Hsuan Lo iD, Zhaoxiang Hong, Jiahao Zheng, Yuhong Yan, Zucheng Ye, Xiaochun Chen, Xiaodong Pan iD

Glia · 2023

DOI: 10.1002/glia.24422 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Glia, 2023. Verfasst von Linjuan Feng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Synucleinopathies refer to a range of neurodegenerative diseases caused by abnormal α‐synuclein (α‐Syn) deposition, including Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA). Their pathogenesis is strongly linked to microglial dysfunction and neuroinflammation, which involves the leucine‐rich‐repeat kinase 2 (LRRK2)‐regulated nuclear factor of activated T‐cells (NFAT). Of the NFAT family, NFATc1 has been found to be increasingly translocated into the nucleus in α‐syn stimulation. However, the specific role of NFATc1‐mediated intracellular signaling in PD remains elusive in regulating microglial functions. In the current study, we crossbred LRRK2 or NFATc1 conditional knockout mice with Lyz2 Cre mice to generate mice with microglia‐specific deletion of LRRK2 or NFATc1, and by stereotactic injection of fibrillary α‐Syn, we generated PD models in these mice. We found that LRRK2 deficiency enhanced microglial phagocytosis in the mice after α‐Syn exposure and that genetic inhibition of NFATc1 markedly diminished phagocytosis and α‐Syn elimination. We further demonstrated that LRRK2 negatively regulated NFATc1 in α‐Syn‐treated microglia, in which microglial LRRK2‐deficiency facilitated NFATc1 nuclear translocation, CX3CR1 upregulation, and microglia migration. Additionally, NFATc1 translocation upregulated the expression of Rab7 and promoted the formation of late lysosomes, resulting in α‐Syn degradation. In contrast, the microglial NFATc1 deficiency impaired CX3CR1 upregulation and the formation of Rab7‐mediated late lysosomes. These findings highlight the critical role of NFATc1 in modulating microglial migration and phagocytosis, in which the LRRK2‐NFATc1 signaling pathway regulates the expression of microglial CX3CR1 and endocytic degradative Rab7 to attenuate α‐synuclein immunotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseAnimalsMiceLeucine-Rich Repeat Serine-Threonine Protein Kinase-2LysosomesMice, KnockoutMicrogliaPhagocytosisCX3C Chemokine Receptor 1NFATC Transcription Factors

Stichwörter der Autor:innen

CX3CR1NFATc1endolysosomal systemmicroglial phagocytosisα-synycleinopathy

Substanzen

alpha-SynucleinLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Cx3cr1 protein, mouseCX3C Chemokine Receptor 1Lrrk2 protein, mouseNfatc1 protein, mouseNFATC Transcription Factors

Autor:innen und Institutionen

  • Department of Neurology, Center for Cognitive Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China.
  • Institute of Clinical Neurology, Fujian Medical University, Fuzhou, China.
  • Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.
  • Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Department of Neurology, The University of HongKong Shenzhen Hospital, Shenzhen, Guangdong, China.

ORCID-Profile: Hsuan Lo, Xiaodong Pan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Feng, L., Lo, H., Hong, Z., Zheng, J., Yan, Y., Ye, Z., Chen, X., & Pan, X. (2023). Microglial LRRK2 ‐mediated NFATc1 attenuates α‐synuclein immunotoxicity in association with CX3CR1 ‐induced migration and the lysosome‐initiated degradation. Glia. https://doi.org/10.1002/glia.24422

Vancouver

Feng L, Lo H, Hong Z, Zheng J, Yan Y, Ye Z, et al. Microglial LRRK2 ‐mediated NFATc1 attenuates α‐synuclein immunotoxicity in association with CX3CR1 ‐induced migration and the lysosome‐initiated degradation. Glia. 2023. doi:10.1002/glia.24422

BibTeX
@article{Feng2023,
  author = {Feng, Linjuan and Lo, Hsuan and Hong, Zhaoxiang and Zheng, Jiahao and Yan, Yuhong and Ye, Zucheng and Chen, Xiaochun and Pan, Xiaodong},
  title = {Microglial LRRK2 ‐mediated NFATc1 attenuates α‐synuclein immunotoxicity in association with CX3CR1 ‐induced migration and the lysosome‐initiated degradation},
  journal = {Glia},
  year = {2023},
  doi = {10.1002/glia.24422}
}
Kostenlos starten →